State Street’s IN8bio INAB Stock Holding History

State Street’s Portfolio INAB Stock Details INAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,958	Closed	-$14.7K	–	4293
2025 Q1	$14.7K	Hold	2,958	–	–	﹤0.01%	4233
2024 Q4	$22.8K	Hold	2,958	–	–	﹤0.01%	4227
2024 Q3	$24K	Hold	2,958	–	–	﹤0.01%	4203
2024 Q2	$75.1K	Buy	2,958 +983	+50%	+$31.5K	﹤0.01%	4068
2024 Q1	$69.9K	Hold	1,975	–	–	﹤0.01%	4102
2023 Q4	$81.8K	Hold	1,975	–	–	﹤0.01%	4092
2023 Q3	$61.6K	Hold	1,975	–	–	﹤0.01%	4232
2023 Q2	$91.2K	Buy	+1,975	New	+$123K	﹤0.01%	4264

Other funds holding INAB

BCM

BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street's INAB Position: Q2 2025 in Review

State Street sold out of IN8bio (INAB) in Q2 2025, closing a stake of 2,958 shares — an estimated $14.7K sold.

State Street first reported a position in INAB in Q2 2023 and held it in 8 quarters. The position peaked at $91.2K in Q2 2023. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

State Street reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
State Street sold 2,958 IN8bio shares in Q2 2025, an estimated $14.7K.
State Street first reported a position in IN8bio in Q2 2023 and held it in 8 quarters.
State Street's IN8bio position peaked at $91.2K in Q2 2023.
12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.